FWIW we have alittle under 300 million people in the US and canada has a little over 30 million people. So we are about 10 times bigger than they are.
We had over 27K transplants..
http://www.kidney.org/news/newsroom/fsitem.cfm?id=30
They had 1905 organ transplants
http://www.lhsc.on.ca/transplant/stats.htm#txcanada
Canadian Organ Replacement Register, Canadian Institute for Health Information, 2006
So per capita we did almost 50% more transplants than they did.
A slightly old but more rigid analysis of kidney transplant in Canada
1: Med Care. 1997 Jul;35(7):686-700.
Mortality, hospital admissions, and medical costs of end-stage renal disease in
the United States and Manitoba, Canada.
Hornberger JC, Garber AM, Jeffery JR.
Department of Health Research and Policy, Stanford University School of
Medicine, CA 94305-5092, USA.
OBJECTIVES: National registry data suggest that mortality rates among patients
with end-stage renal disease are lower in Canada than in the United States.
Casemix and treatment variables, although limited in such instances, do not
explain this difference. Using a more complete set of casemix and treatment
variables from clinical databases, this study assesses mortality, hospital
admission, and the cost of medical care for patients with end-stage renal
disease treated in Manitoba, Canada and the United States. METHODS: Mortality
rates were compared in patients with end-stage renal disease treated in the
Province of Manitoba and a random sample of US patients enrolled in the US Renal
Data System Casemix Severity Study. Hospital admission rates and costs of care
were compared in Manitoba patients and in patients with end-stage renal disease
in a large health care organization in Detroit, Michigan. RESULTS: Levels of
serum creatinine, urea, and estimated glomerular filtration rate indicated more
severe renal impairment at the outset of treatment in Manitoba than in the
United States. Manitoba patients were more than twice as likely to receive
kidney transplants as US Renal Data System patients. No patients in Manitoba
used reprocessed dialyzers, compared with 57% of US Renal Data System patients.
After adjustment for all casemix and treatment variables, the mortality rate was
47% higher in the United States. The hospital admission rate in Detroit was 41%
lower than the hospital admission rate in Manitoba, which primarily reflects the
doubled rate of transplantation in Manitoba. Adjusted total monthly costs were
$503 higher in Detroit than in Manitoba. CONCLUSIONS: The higher mortality rates
in the United States cannot be fully explained by adjustments for observable
casemix or treatment variables. Further research is needed to identify factors
that explain how Manitoba achieves a lower mortality rate while paying less for
end-stage renal disease care than the United States.